← Compounds
Cortexin
peptide · headlineResearch use onlyModulates expression of neurotrophic factors such as BDNF and NGF
Summary
Cortexin is a peptide-based neurobioregulator derived from bovine brain extracts, widely used in Eastern Europe for cognitive decline, stroke recovery, and neurodevelopmental disorders. It exerts neuroprotective, metabolic, and anti-inflammatory effects, enhancing memory, learning, and synaptic repair.
How it works
- Modulates expression of neurotrophic factors such as BDNF and NGF
- Improves metabolic support for neurons by enhancing cerebral glucose and oxygen use
- Reduces excitotoxicity and regulates glutamate and GABA balance
- Exerts antioxidant and anti-inflammatory effects in the CNS
Dosing
- unit: mglow dose: 5frequency: Once daily for 10 days per cyclehigh dose: 20standard dose: 10administration route: Intramuscular (IM)
Cycling
- Inject 10 mg daily for 10 consecutive days. Repeat cycle every 3–6 months for chronic neurological support or cognitive maintenance.
Side effects
common: ["Mild headache","Injection site irritation"]
warnings: ["May cause overstimulation or restlessness in sensitive individuals"]
long term: ["No significant adverse effects reported in existing clinical studies"]
Chemistry & PK
sequence: Derived from polypeptide fractions of bovine cerebral cortex
half life: Not clearly defined; sustained biological activity observed
degradation: Hydrolyzed by tissue peptidases
molecular formula: Varied (Bioregulator Peptide Complex)
tissue specificity: High brain tissue specificity due to peptide fraction targeting
Verified citations
3 · PubMed-checked- Peptide drug cortexin inhibits brain caspase-8.mechanismPMID 28251948 ↗
- An open clinical trial of cortexin in treatment of brain ischemia.clinicalPMID 25403301 ↗
- Cortexin. Molecular mechanisms and targets of neuroprotective activity.reviewPMID 26356623 ↗
Used for
No condition evidence rows yet.
Legal / compounding
Research use only
Legal status is a hard gate: non-compoundable or delisted agents cannot be filled and are blocked from protocol export. Keep 503A status current.